Request Demo
Last update 14 Nov 2026
NT Biopharmaceuticals Jiangsu Co., Ltd.
Last update 14 Nov 2026
Overview
Related
ChiCTR-IPR-14005363
The Random Open, Multicenter Clinical Study of CDA -II in the Treatment of Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) .
100 Clinical Results associated with NT Biopharmaceuticals Jiangsu Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with NT Biopharmaceuticals Jiangsu Co., Ltd.
Login to view more data
100 Translational Medicine associated with NT Biopharmaceuticals Jiangsu Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Nov 2026
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free